Impressive Continuous Complete Response after Mogamulizumab in a Heavily Pretreated Sézary Syndrome Patient

BACKGROUND: Sézary syndrome (SS) is a rare lymphoproliferative neoplasm, almost incurable outside the setting of allogeneic transplantable patients. The prognosis for relapsed/refractory patients remains poor, as the available drugs confer short-lasting remission. In this setting, the anti-chemokine...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Mediterr J Hematol Infect Dis
Asıl Yazarlar: Lolli, Ginevra, Casadei, Beatrice, Argnani, Lisa, Nanni, Laura, Cavo, Michele, Zinzani, Pier Luigi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Università Cattolica del Sacro Cuore 2020
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7340218/
https://ncbi.nlm.nih.gov/pubmed/32670518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4084/MJHID.2020.040
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller